VistaGen Therapeutics, Inc.
VTGN
$0.70
$0.0913.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -69.69M | -67.05M | -62.24M | -55.78M | -51.42M |
| Total Depreciation and Amortization | 733.00K | 709.00K | 681.00K | 653.00K | 635.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.45M | 3.53M | 3.56M | 3.58M | 3.93M |
| Change in Net Operating Assets | -938.00K | 2.51M | 5.05M | 1.47M | 4.76M |
| Cash from Operations | -66.44M | -60.30M | -52.95M | -50.07M | -42.10M |
| Capital Expenditure | -151.00K | -239.00K | -213.00K | -214.00K | -191.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -726.00K | -12.00K | -564.00K | -8.26M | -12.96M |
| Cash from Investing | -877.00K | -251.00K | -777.00K | -8.47M | -13.15M |
| Total Debt Issued | 1.02M | 1.02M | 1.02M | 1.02M | -- |
| Total Debt Repaid | -925.00K | -642.00K | -364.00K | -90.00K | -- |
| Issuance of Common Stock | 30.88M | 32.83M | 31.61M | 3.68M | 3.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.97M | 33.21M | 32.26M | 4.61M | 3.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.34M | -27.34M | -21.46M | -53.93M | -52.04M |